395 related articles for article (PubMed ID: 34605898)
1. Personalized brain models identify neurotransmitter receptor changes in Alzheimer's disease.
Khan AF; Adewale Q; Baumeister TR; Carbonell F; Zilles K; Palomero-Gallagher N; Iturria-Medina Y;
Brain; 2022 Jun; 145(5):1785-1804. PubMed ID: 34605898
[TBL] [Abstract][Full Text] [Related]
2. Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer's disease.
Biel D; Luan Y; Brendel M; Hager P; Dewenter A; Moscoso A; Otero Svaldi D; Higgins IA; Pontecorvo M; Römer S; Steward A; Rubinski A; Zheng L; Schöll M; Shcherbinin S; Ewers M; Franzmeier N;
Alzheimers Res Ther; 2022 Nov; 14(1):166. PubMed ID: 36345046
[TBL] [Abstract][Full Text] [Related]
3. Molecular properties underlying regional vulnerability to Alzheimer's disease pathology.
Grothe MJ; Sepulcre J; Gonzalez-Escamilla G; Jelistratova I; Schöll M; Hansson O; Teipel SJ;
Brain; 2018 Sep; 141(9):2755-2771. PubMed ID: 30016411
[TBL] [Abstract][Full Text] [Related]
4. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
[TBL] [Abstract][Full Text] [Related]
5. Nonlinear changes in delayed functional network topology in Alzheimer's disease: relationship with amyloid and tau pathology.
Mijalkov M; Veréb D; Canal-Garcia A; Hinault T; Volpe G; Pereira JB;
Alzheimers Res Ther; 2023 Jun; 15(1):112. PubMed ID: 37328909
[TBL] [Abstract][Full Text] [Related]
6. Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer's disease.
Sanchez-Rodriguez LM; Bezgin G; Carbonell F; Therriault J; Fernandez-Arias J; Servaes S; Rahmouni N; Tissot C; Stevenson J; Karikari TK; Ashton NJ; Benedet AL; Zetterberg H; Blennow K; Triana-Baltzer G; Kolb HC; Rosa-Neto P; Iturria-Medina Y
Commun Biol; 2024 May; 7(1):528. PubMed ID: 38704445
[TBL] [Abstract][Full Text] [Related]
7. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
Sintini I; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Martin PR; Jones DT; Boeve BF; Knopman DS; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
Brain; 2020 Jul; 143(7):2281-2294. PubMed ID: 32572464
[TBL] [Abstract][Full Text] [Related]
9. Integrated transcriptomic and neuroimaging brain model decodes biological mechanisms in aging and Alzheimer's disease.
Adewale Q; Khan AF; Carbonell F; Iturria-Medina Y;
Elife; 2021 May; 10():. PubMed ID: 34002691
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Alzheimer's disease pathology to biological and clinical progression: A longitudinal study across two cohorts.
Zhang W; Wang HF; Kuo K; Wang L; Li Y; Yu J; Feng J; Cheng W
Alzheimers Dement; 2023 Aug; 19(8):3602-3612. PubMed ID: 36840615
[TBL] [Abstract][Full Text] [Related]
11. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
13. PET Imaging of Tau Pathology and Amyloid-β, and MRI for Alzheimer's Disease Feature Fusion and Multimodal Classification.
Shojaie M; Tabarestani S; Cabrerizo M; DeKosky ST; Vaillancourt DE; Loewenstein D; Duara R; Adjouadi M
J Alzheimers Dis; 2021; 84(4):1497-1514. PubMed ID: 34719488
[TBL] [Abstract][Full Text] [Related]
14. Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer's Disease.
Sintini I; Graff-Radford J; Jones DT; Botha H; Martin PR; Machulda MM; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
Cereb Cortex; 2021 Feb; 31(3):1693-1706. PubMed ID: 33152765
[TBL] [Abstract][Full Text] [Related]
15. Update on neuroimaging in Alzheimer's disease.
Sintini I; Whitwell JL
Curr Opin Neurol; 2021 Aug; 34(4):525-531. PubMed ID: 33928929
[TBL] [Abstract][Full Text] [Related]
16. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
18. The BIN1 rs744373 Alzheimer's disease risk SNP is associated with faster Aβ-associated tau accumulation and cognitive decline.
Franzmeier N; Ossenkoppele R; Brendel M; Rubinski A; Smith R; Kumar A; Mattsson-Carlgren N; Strandberg O; Duering M; Buerger K; Dichgans M; Hansson O; Ewers M;
Alzheimers Dement; 2022 Jan; 18(1):103-115. PubMed ID: 34060233
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of dementia.
Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
[TBL] [Abstract][Full Text] [Related]
20. Association between long-term donepezil treatment and brain regional amyloid and tau burden among individuals with mild cognitive impairment assessed using
Li J; Zheng C; Ge Q; Yan S; Paranjpe MD; Hu S; Zhou Y;
J Neurosci Res; 2022 Feb; 100(2):670-680. PubMed ID: 34882830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
